Map Key
Generic Enzyme
Generic kinase
Protein kinase
Lipid kinase
Generic phosphatase
Protein phosphatase
Lipid phosphatase
Generic phospholipase
Generic protease
Metalloprotease
G-alpha
RAS - superfamily
G beta/gamma
Regulators (GDI, GAP, GEF)
Generic channel
Ligand-gated channel
Voltage-gated channel
Transporter
Normal process
Pathological process
Positive effect
Negative effect
Unspecified effect
Technical link
Disrupts in disease
Emerges in disease
Enhances in disease
Weakens in disease
Organsim specific interaction

Generic binding protein
Receptor ligand
Cell membrane glycoprotein
Transcription factor
DNA
RNA
Compound
Inorganic ion
Predicted metabolite or user's structure
Reaction
Generic receptor
GPCR
Receptors with enzyme activity
Mitochondria
EPR
Golgi
Nucleus
Lysosome
Peroxisome
Cytoplasm
Extracellular

Normal process
Pathological process
Binding
Cleavage
Covalent modifications
Phosphorylation
Dephosphorylation
Transformation
Transport
Catalysis
Transcription regulation
MicroRNA binding
Competition
Influence on expression
Unspecified interactions
Pharmacological effect
Toxic effect
Group relation
Complex subunit
Similarity reaction
A complex or a group
Organism specific object

DNA damage Role of Brca1 and Brca2 in DNA repair


Log In to Post A Comment

DNA damage Role of Brca1 and Brca2 in DNA repair

Role of Brca1 and Brca2 in DNA Repair

DNA damage-dependent activation of the breast and ovarian cancer susceptibilityprotein 1 ( Brca1 ) occurs via activation of ataxia telangiectasia mutatedserine-protein kinase ( ATM ) [1] or ataxia telangiectasia and Rad3related protein kinase ( ATR ) [2]. These kinases phosphorylateBrca1 directly or indirectly (via c ell cycle checkpoint kinase 2 ( Chk2 )[3]). Phosphorylated by ATM and ATR histones ( H2AX )are co-localized together with some proteins to form nuclear foci at DNA damage sites.The loci can include the tumor protein 53-binding protein, 1 ( 53BP1 ) andthe nuclear factor with BRCT domians protein 1 ( NFBD1 ), which take partin activation of Chk2 [4], MRN complex (consisting fromdouble-strand break repair protein ( Mre11 ), Rad50 homolog (S. cerevisiae) (Rad50 ) and Nijmegen breakage syndrome 1 protein ( Nibrin )) is a part ofthese foci, as well.

One suggested response of Brca1 to DNA damage consists of monoubiquitination ofH2AX, followed by remodeling the chromatin in such a way that damaged DNA becomesassessable to the DNA repair machinery [5]. E3 ubiquitin ligase activity ofBrca1 considerably amplifies, if Brca1 forms a complex with a Brca1associated RING domain protein 1 ( BARD1 ) [6].

Brca1 plays a central role in DNA repair by facilitating cellular response toDNA repair. There are numerous DNA repair pathways directed to the specific types ofdamage, and a given type of damage can be targeted by several pathways. Major DNA repairpathways are mismatch repair (MMR), nucleotide excision repair (NER), base excisionrepair (BER), homologous recombinational repair (HRR), and non-homologous end joining(NHEJ) [7].

Brca1 participates in all these pathways.

Participation Brca1 in NER is mediated by transcription factors p53 andSP1. These TFs activate transcription of damage-specific DNA binding protein 2 (DDB2 ) and xeroderma pigmentosum group C protein ( XPC ). In addition,activated by Brca1, p53 participates in BER by exciting transcription ofproliferating cell nuclear antigen ( PCNA ) and stimulating activity of theendonuclease III-like 1 enzyme ( Nth1 ).

Moreover, Brca1 seems to be involved in DNA repair processes such astranscription-coupled repair (TCR) via activation of RNA polymerase II transcriptionmachinery [8], [9].

Both Brca1 and Brca2 are implicated in HRR via DNA repair protein,S.cerevisiae homolog RAD51. RAD51 is a key component of the mechanism inwhich DNA damage is repaired by homologous recombination [10]. Moreover,Brca1 may activate Brca1 interacting protein C-terminal helicase 1 ( BRIP1) [11]. BRIP1 is able to catalytically release the third strand of thehomologous recombination intermediate D-loop structure irrespective of DNA tail status[12].

It is shown that Fanconi anemia complementation group D2 protein, isoform 1 (FANCD2 ) (in a complex with RAD51 and/or Brca s) participates in HRR[13]. At the same time, FANCD2 should be ubiquitinated (by a complexof Fanconi anemia proteins ( FANC complex ), for example) [14].Moreover, Fanconi anemia proteins/ Brca1 pathway participates in DNA interstrandcross-link (ICL) repair [15].

Role of Brca1 in NHEJ consists of regulation of the MRN complex.Phosphorylated by Chk2, Brca1 inhibits Mre11. It depresses NHEJpathway and stimulates HRR RAD51 -dependent pathway [3]. In addition,Brca1 may stimulate HRR and NHEJ via activation of Rad50 [16], [17].

Brca1 and BARD1 are downstream effectors of the adenosinenucleotide-activated DNA mismatch repair protein signaling complex ( MSH2,MSH3, MSH6, MLH1 ), and suggest a global role for Brca1 inMMR [18]. It is shown, that p53 take part of MMR [19].